{
    "clinical_study": {
        "@rank": "123008", 
        "arm_group": [
            {
                "arm_group_label": "Phase I: 75.25 Gy/36 fx + chemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 75.25 Gy given in 36 fractions (2.15 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional."
            }, 
            {
                "arm_group_label": "Phase I: 74 Gy/37 fx + chemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional."
            }, 
            {
                "arm_group_label": "Phase I: 70 Gy/35 fx + chemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 70 Gy given in 35 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional."
            }, 
            {
                "arm_group_label": "Phase II: 74 Gy/37 fx + chemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Phase II: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional."
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in\n      chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells\n      from dividing so they stop growing or die. Combining more than one drug and giving them with\n      specialized radiation therapy may kill more tumor cells.\n\n      PURPOSE: This phase I/II trial is studying the effectiveness of radiation therapy combined\n      with paclitaxel and carboplatin in treating patients who have stage III non-small cell lung\n      cancer."
        }, 
        "brief_title": "Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 75.25 Gy given in 36 fractions (2.15 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 75.25 Gy/36 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 74 Gy/37 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Phase II: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase II: 74 Gy/37 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "44"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "61"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@lower_limit": "48", 
                                                "@upper_limit": "77", 
                                                "@value": "65.5"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@lower_limit": "52", 
                                                "@upper_limit": "81", 
                                                "@value": "68"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@lower_limit": "43", 
                                                "@upper_limit": "83", 
                                                "@value": "67"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@lower_limit": "43", 
                                                "@upper_limit": "83", 
                                                "@value": "67"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Median", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "16"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "37"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "45"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "Eligible patients who started protocol treatment."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "This study was originally designed to escalate 3DRT via increasing doses per fraction. However, due to excessive toxicity at dose level 1 (75.25 Gy, 2.15 Gy/fraction), the protocol was amended in January 2003 to de-escalate 3DRT dose.", 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Dose limiting toxicity (DLT) = Grade 3/4 non-hematologic toxicities (excluding nausea, vomiting, and alopecia) and Grade 4 hematologic toxicities. The DLT rate for this study was set at 40% based on RTOG (Radiation Therapy Oncolgy Group) study 94-10. No acute (within 90 days from start of 3DRT) DLT's in the first 5 patients (0/5) or the combination of one acute DLT in the first 5 patients (1/5) and none in the next 2 patients (0/2) was required to deem a given dose level to be acceptable.  If at any time a Grade 5 toxicity (death) occurred, accrual would be suspended and the event reviewed by a study chair.  At any given dose level, this design gives at least 90% confidence that the true acute DLT rate is less than 40% and the probability of not escalating when the true toxicity rate is 40% or higher is at least 83%.\nRating scale:  0 = not the MTD, 1 = MTD", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 75.25 Gy given in 36 fractions (2.15 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                                    "title": "Phase I: 75.25 Gy/36 fx + Chemotherapy"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                                    "title": "Phase I: 74 Gy/37 fx + Chemotherapy"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "7"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "1"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Dose limiting toxicity (DLT) = Grade 3/4 non-hematologic toxicities (excluding nausea, vomiting, and alopecia) and Grade 4 hematologic toxicities. The DLT rate for this study was set at 40% based on RTOG (Radiation Therapy Oncolgy Group) study 94-10. No acute (within 90 days from start of 3DRT) DLT's in the first 5 patients (0/5) or the combination of one acute DLT in the first 5 patients (1/5) and none in the next 2 patients (0/2) was required to deem a given dose level to be acceptable.  If at any time a Grade 5 toxicity (death) occurred, accrual would be suspended and the event reviewed by a study chair.  At any given dose level, this design gives at least 90% confidence that the true acute DLT rate is less than 40% and the probability of not escalating when the true toxicity rate is 40% or higher is at least 83%.\nRating scale:  0 = not the MTD, 1 = MTD", 
                                    "param": "Number", 
                                    "title": "Maximum Tolerated Dose (MTD) of Three-dimensional Conformal Radiation Therapy (3DRT), in Terms of Gy Per Fraction, Combined With Concurrent Chemotherapy", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "The first seven eligible patients who started protocol treatment at each dose level.", 
                        "safety_issue": "Yes", 
                        "time_frame": "From start of treatment to 90 days", 
                        "title": "Maximum Tolerated Dose (MTD) of Three-dimensional Conformal Radiation Therapy (3DRT), in Terms of Gy Per Fraction, Combined With Concurrent Chemotherapy", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Null hypothesis: p<= 62.3% (the best arm of RTOG 94-10); alternative hypothesis:  p>= 77.9%. Where p is the percentage of patients alive at at 12 months.  Using a one-group chi-square test with alpha = 0.10, a sample size of 50 patients provides at least 87% power to detect a 25% or greater relative increase in the 12-month survival rate, or equivalently, an absolute increase of at least 15.6 percentage points (62.3 versus 77.9).  If the point estimate is greater than 71.1% (upper bound), then the conclusion is that the 12-month survival rate from the new treatment significantly improved from 62.3%.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Phase I/II: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.\ncarboplatin\npaclitaxel\nthree-dimensional conformal radiation therapy", 
                                "title": "Phase I/II: 74 Gy/37 fx + Chemotherapy"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "53"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "61.5", 
                                                    "@upper_limit": "85.0", 
                                                    "@value": "75.5"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Null hypothesis: p<= 62.3% (the best arm of RTOG 94-10); alternative hypothesis:  p>= 77.9%. Where p is the percentage of patients alive at at 12 months.  Using a one-group chi-square test with alpha = 0.10, a sample size of 50 patients provides at least 87% power to detect a 25% or greater relative increase in the 12-month survival rate, or equivalently, an absolute increase of at least 15.6 percentage points (62.3 versus 77.9).  If the point estimate is greater than 71.1% (upper bound), then the conclusion is that the 12-month survival rate from the new treatment significantly improved from 62.3%.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Number", 
                                    "title": "Percentage of Patients Who Survive at Least 12 Months", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Eligible patients at the MTD dose level who started protocol treatment.", 
                        "safety_issue": "No", 
                        "time_frame": "From registration to 1 year", 
                        "title": "Percentage of Patients Who Survive at Least 12 Months", 
                        "type": "Primary"
                    }, 
                    {
                        "safety_issue": "Yes", 
                        "time_frame": "From start of treatment to end of follow-up", 
                        "title": "Toxicity", 
                        "type": "Secondary"
                    }, 
                    {
                        "safety_issue": "Yes", 
                        "time_frame": "From start of treatment to end of follow-up", 
                        "title": "Partial Organ Tolerance Doses for Lung and Esophagus", 
                        "type": "Secondary"
                    }, 
                    {
                        "safety_issue": "No", 
                        "time_frame": "From start of treatment until 3 months after completion of therapy", 
                        "title": "Complete Response Rate at 3 Months After Therapy", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 75.25 Gy given in 36 fractions (2.15 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 75.25 Gy/36 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 74 Gy/37 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 70 Gy given in 35 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 70 Gy/35 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Phase II: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase II: 74 Gy/37 fx + Chemotherapy"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Ineligible / no protocol treatment"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Patient withdrew consent"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "8", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "46", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "Phase I eligible patients starting protocol treatment are considered to have completed the study.", 
                                                "@count": "8", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "Phase I eligible patients starting protocol treatment are considered to have completed the study.", 
                                                "@count": "9", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "#text": "This arm was not used since further de-escalation was not required.", 
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "#text": "Phase II subjects contributing data to primary analysis are considered to have completed the study.", 
                                                "@count": "44", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "wseiferheld@acr.org", 
                "name_or_title": "Wendy Seiferheld", 
                "organization": "Radiation Therapy Oncology Group"
            }, 
            "reported_events": {
                "desc": "Subjects experiencing more than one of a given SAE (serious adverse event) are counted only once for that SAE.  The same methodology was applied for non-SAE adverse events (AE).", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 75.25 Gy given in 36 fractions (2.15 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I: 75.25 Gy/36 fx + Chemotherapy"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Phase I: Three-dimensional conformal radiation therapy (3DRT) of 74 Gy given in 37 fractions (2.0 Gy per fraction) with concurrent chemotherapy consisting of weekly paclitaxel at 50mg/m2 and carboplatin at area under the curve 2mg/m2.  Adjuvant systemic chemotherapy (two cycles of paclitaxel and carboplatin) following completion of RT was optional.", 
                            "title": "Phase I/II: 74 Gy/37 fx + Chemotherapy"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "52", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hematologic-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "34", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hemoglobin decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pericardial effusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Sinus tachycardia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Supraventricular arrhythmia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Hearing-Other", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Ear and labyrinth disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Abdominal pain NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Constipation", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Diarrhea NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dry mouth", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dyspepsia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dysphagia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Esophageal spasm", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Esophagitis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "GI-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Gastritis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Nausea", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Radiation mucositis", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Rectal bleeding", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Stomatitis", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Vomiting NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Chest pain", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Edema NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "40", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Fatigue", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Bone", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Esophagus", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Heart", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "26", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Lung", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Other", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Skin (within the irradiated field)", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Spinal cord", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Subcutaneous tissue", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pain due to radiation", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pain-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pyrexia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Rigors", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Hepatic-Other", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Hypersensitivity NOS", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection with unknown ANC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "14", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Dermatitis radiation NOS", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Activated partial thromboplastin time prolonged", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Alanine aminotransferase increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Aspartate aminotransferase increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood alkaline phosphatase NOS increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood bilirubin increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood creatine phosphokinase increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood creatinine increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Forced expiratory volume decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "29", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Leukopenia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Lymphopenia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Metabolic-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "25", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Neutropenia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "20", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Platelet count decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Prothrombin time prolonged", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Weight decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Anorexia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood albumin decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood bicarbonate decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Blood magnesium decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dehydration", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypercalcemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hyperglycemia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hyperkalemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypernatremia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypocalcemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypoglycaemia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypokalemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hyponatremia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypophosphatemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Bone pain", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Joint, muscle, or bone-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Myalgia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Amnesia NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Ataxia NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Convulsions NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dizziness (exc vertigo)", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Headache NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Neuralgia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Neurologic-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Peripheral motor neuropathy", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Peripheral sensory neuropathy", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Speech disorder NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Taste disturbance", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Tremor NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Anxiety NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Confusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Depression NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Insomnia NEC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Libido decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Renal failure NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Renal/GU-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Ureteric obstruction", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Urinary frequency", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "24", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Cough", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dysphonia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dyspnea NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Epistaxis", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hemoptysis", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hiccups", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pleural effusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pleuritic pain", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pneumonitis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pneumothorax NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pulmonary-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Alopecia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dermatitis exfoliative NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dry skin", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Erythema multiforme", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Nail abnormality NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Skin discoloration", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Skin-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Flushing", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypertension NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypotension NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "CTC 2.0", 
                    "frequency_threshold": "0"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "36", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hemoglobin decreased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hemolysis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Packed red blood cell transfusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Platelet transfusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Arrhythmia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Sinus tachycardia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Supraventricular arrhythmia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dyspepsia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dysphagia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Esophageal spasm", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Esophagitis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "GI-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Ileus", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Nausea", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Vomiting NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Esophagus", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Heart", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Lung", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Late RT Toxicity: Other", 
                                                "@vocab": "RTOG/EORTC Late Tox."
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pain-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Hypersensitivity NOS", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection with grade 3 or 4 neutropenia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection with unknown ANC", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Infection, Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dermatitis radiation NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Operative injury of vein/artery", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Cardiac troponin I increased", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Leukopenia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Lymphopenia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Neutropenia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Anorexia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dehydration", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hyperglycemia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypokalemia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "8"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "53"
                                            }
                                        ], 
                                        "sub_title": {
                                            "#text": "Muscle weakness NOS", 
                                            "@vocab": "CTCAE (2.0)"
                                        }
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Convulsions NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Syncope", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Renal failure NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Renal/GU-Other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Dyspnea NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hemoptysis", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypoxia", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pleural effusion", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pneumonitis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Pulmonary-other", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Hypotension NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Peripheral ischaemia NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "8"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "53"
                                                }
                                            ], 
                                            "sub_title": {
                                                "#text": "Thrombosis NOS", 
                                                "@vocab": "CTCAE (2.0)"
                                            }
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "CTC 2.0"
                }
            }
        }, 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the maximum tolerated dose of 3-dimensional conformal radiotherapy when\n           administered concurrently with paclitaxel and carboplatin in patients with inoperable\n           stage IIIA or IIIB non-small cell lung cancer. (Phase I) (Closed to accrual as of\n           01/13/04.)\n\n        -  Determine the 12-month survival rate in patients treated with this regimen. (Phase II)\n           (Closed to accrual as of 11/27/07.)\n\n        -  Determine the toxicity of this regimen in these patients.\n\n        -  Determine the partial organ tolerance doses for the lung and esophagus in patients\n           treated with this regimen.\n\n        -  Determine the complete response rate in patients treated with this regimen.\n\n      OUTLINE: This is a multicenter, dose-escalation study of 3-dimensional conformal\n      radiotherapy.\n\n        -  Phase I (closed to accrual as of 01/13/04): Patients undergo 3-dimensional conformal\n           radiotherapy once daily five days a week for 7-8 weeks. Patients also receive\n           concurrent chemotherapy comprising paclitaxel IV over 1 hour followed by carboplatin IV\n           over 30 minutes on days 1, 8, 15, 22, 29, 36, and 43.\n\n      Cohorts of 7-9 patients receive de-escalating doses of 3-dimensional conformal radiotherapy\n      until the maximum tolerated dose (MTD) is determined when given in combination with\n      chemotherapy. The MTD is defined as the highest dose at which no more than 1 patient\n      experiences dose-limiting toxicity.\n\n        -  Phase II: Additional patients are accrued and treated as above at the MTD. At least 3\n           weeks after completing radiotherapy, patients may receive additional chemotherapy\n           comprising paclitaxel IV over 3 hours once and carboplatin IV over 30 minutes once.\n           Treatment with paclitaxel and carboplatin may repeat every 3 weeks for up to 2 courses.\n\n      Patients are followed every 3 months for 1 year, every 4 months for 1 year, every 6 months\n      for 3-5 years, and then annually thereafter.\n\n      PROJECTED ACCRUAL: A maximum of 73 patients (up to 27 for phase I [closed to accrual as of\n      10/28/04] and 46 for phase II) will be accrued for this study within 1-1.5 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed unresectable stage IIIB non-small cell lung\n             cancer\n\n               -  Squamous cell carcinoma\n\n               -  Adenocarcinoma\n\n               -  Large cell carcinoma\n\n               -  Non-small cell carcinoma not otherwise specified\n\n          -  All detectable primary tumor and involved regional lymph nodes must be encompassed by\n             radiotherapy fields\n\n          -  Measurable disease on 3-dimensional planning CT scan\n\n          -  No undifferentiated small cell (oat cell or high-grade neuroendocrine) carcinoma\n\n          -  No stage IV or recurrent disease\n\n          -  No distant metastases or supraclavicular lymph node involvement\n\n          -  No significant atelectasis (i.e., atelectasis of an entire lung)\n\n          -  No pleural effusions, pericardial effusions, or superior vena cava syndrome\n\n          -  No lung cancer within the past 2 years\n\n          -  Ineligible for currently open Radiation Therapy Oncology Group (RTOG) phase III lung\n             protocols\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Zubrod 0-1\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Granulocyte count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n        Hepatic:\n\n          -  Bilirubin less than 1.5 mg/dL\n\n          -  Aspartate aminotransferase (AST) less than 2 times upper limit of normal\n\n        Renal:\n\n          -  Creatinine no greater than 2.0 mg/dL\n\n        Pulmonary:\n\n          -  Forced expiratory volume (FEV)_1 at least 1.0 L\n\n        Other:\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception\n\n          -  No weight loss greater than 5% in the past 6 months\n\n          -  No other malignancy within the past year except nonmelanoma skin cancer\n\n          -  Completed 3D plan with total lung V20 </= 30% mean esophageal dose </= 34 Gy and\n             esophageal V55 </= 30%\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No prior biologic response modifiers for current lung cancer\n\n          -  At least 5 years since prior biologic response modifiers\n\n        Chemotherapy:\n\n          -  No prior chemotherapy for current lung cancer\n\n          -  At least 5 years since prior chemotherapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  See Disease Characteristics\n\n          -  No prior radiotherapy to the thorax\n\n        Surgery:\n\n          -  No prior complete tumor resection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "63", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 13, 2001", 
        "firstreceived_results_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00023673", 
            "org_study_id": "RTOG L-0117", 
            "secondary_id": [
                "CDR0000068850", 
                "NCI-2012-02401"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Phase I: 75.25 Gy/36 fx + chemotherapy", 
                    "Phase I: 74 Gy/37 fx + chemotherapy", 
                    "Phase I: 70 Gy/35 fx + chemotherapy", 
                    "Phase II: 74 Gy/37 fx + chemotherapy"
                ], 
                "intervention_name": "carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Phase I: 75.25 Gy/36 fx + chemotherapy", 
                    "Phase I: 74 Gy/37 fx + chemotherapy", 
                    "Phase I: 70 Gy/35 fx + chemotherapy", 
                    "Phase II: 74 Gy/37 fx + chemotherapy"
                ], 
                "intervention_name": "paclitaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Phase I: 75.25 Gy/36 fx + chemotherapy", 
                    "Phase I: 74 Gy/37 fx + chemotherapy", 
                    "Phase I: 70 Gy/35 fx + chemotherapy", 
                    "Phase II: 74 Gy/37 fx + chemotherapy"
                ], 
                "intervention_name": "three-dimensional conformal radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "squamous cell lung cancer", 
            "large cell lung cancer", 
            "stage IIIA non-small cell lung cancer", 
            "stage IIIB non-small cell lung cancer", 
            "adenocarcinoma of the lung", 
            "adenosquamous cell lung cancer"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/RTOG-L-0117"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36652-2144"
                    }, 
                    "name": "Mobile Infirmary Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85013"
                    }, 
                    "name": "Arizona Oncology Services Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burbank", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91505"
                    }, 
                    "name": "Providence Saint Joseph Medical Center - Burbank"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mission Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91346-9600"
                    }, 
                    "name": "Providence Holy Cross Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95817"
                    }, 
                    "name": "University of California Davis Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Panama City", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32401"
                    }, 
                    "name": "Bay Medical"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30501"
                    }, 
                    "name": "Northeast Georgia Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alton", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62002"
                    }, 
                    "name": "Saint Anthony's Hospital at Saint Anthony's Health Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elk Grove Village", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60007"
                    }, 
                    "name": "Alexian Brothers Radiation Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mt. Vernon", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62864"
                    }, 
                    "name": "Good Samaritan Regional Health Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hammond", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46320"
                    }, 
                    "name": "Oncology Center at Saint Margaret Mercy Healthcare Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muncie", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47303-3499"
                    }, 
                    "name": "Cancer Center at Ball Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pascagoula", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39581"
                    }, 
                    "name": "Regional Cancer Center at Singing River Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Girardeau", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63703"
                    }, 
                    "name": "Cancer Institute of Cape Girardeau, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Girardeau", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63703"
                    }, 
                    "name": "Saint Francis Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gape Girardeau", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63701"
                    }, 
                    "name": "Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "David C. Pratt Cancer Center at St. John's Mercy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65807"
                    }, 
                    "name": "Hulston Cancer Center at Cox Medical Center South"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65802"
                    }, 
                    "name": "CCOP - Cancer Research for the Ozarks"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "CCOP - St. Louis-Cape Girardeau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brick", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08724"
                    }, 
                    "name": "Ocean Medical Center at Meridian Health"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toms River", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08755"
                    }, 
                    "name": "J. Phillip Citta Regional Cancer Center at Community Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vineland", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08360"
                    }, 
                    "name": "Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13057"
                    }, 
                    "name": "CCOP - Hematology-Oncology Associates of Central New York"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "High Point", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27261"
                    }, 
                    "name": "High Point Regional Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44309-2090"
                    }, 
                    "name": "Summa Center for Cancer Care at Akron City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44111"
                    }, 
                    "name": "Cleveland Clinic Cancer Center at Fairview Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Taussig Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wooster", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44691"
                    }, 
                    "name": "Cancer Treatment Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grants Pass", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97527"
                    }, 
                    "name": "Three Rivers Community Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97504"
                    }, 
                    "name": "Dubs Cancer Center at Rogue Valley Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97504"
                    }, 
                    "name": "Providence Cancer Center at PMCC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19141"
                    }, 
                    "name": "Albert Einstein Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota", 
                        "zip": "57701"
                    }, 
                    "name": "Rapid City Regional Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77555-0361"
                    }, 
                    "name": "University of Texas Medical Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79410-1894"
                    }, 
                    "name": "Joe Arrington Cancer Research and Treatment Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wheeling", 
                        "country": "United States", 
                        "state": "West Virginia", 
                        "zip": "26003"
                    }, 
                    "name": "Schiffler Cancer Center at Wheeling Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Crosse", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54601"
                    }, 
                    "name": "Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Medical College of Wisconsin Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53295"
                    }, 
                    "name": "Veterans Affairs Medical Center - Milwaukee"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T2N 4N2"
                    }, 
                    "name": "Tom Baker Cancer Centre - Calgary"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy And Concurrent Chemotherapy For Patients With Inoperable, Non-Small Cell Lung Cancer", 
        "overall_official": {
            "affiliation": "Mallinckrodt Institute of Radiology at Washington University Medical Center", 
            "last_name": "Jeffrey Bradley, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "January 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Dose limiting toxicity (DLT) = Grade 3/4 non-hematologic toxicities (excluding nausea, vomiting, and alopecia) and Grade 4 hematologic toxicities. The DLT rate for this study was set at 40% based on RTOG (Radiation Therapy Oncolgy Group) study 94-10. No acute (within 90 days from start of 3DRT) DLT's in the first 5 patients (0/5) or the combination of one acute DLT in the first 5 patients (1/5) and none in the next 2 patients (0/2) was required to deem a given dose level to be acceptable.  If at any time a Grade 5 toxicity (death) occurred, accrual would be suspended and the event reviewed by a study chair.  At any given dose level, this design gives at least 90% confidence that the true acute DLT rate is less than 40% and the probability of not escalating when the true toxicity rate is 40% or higher is at least 83%.\nRating scale:  0 = not the MTD, 1 = MTD", 
                "measure": "Maximum Tolerated Dose (MTD) of Three-dimensional Conformal Radiation Therapy (3DRT), in Terms of Gy Per Fraction, Combined With Concurrent Chemotherapy", 
                "safety_issue": "Yes", 
                "time_frame": "From start of treatment to 90 days"
            }, 
            {
                "description": "Null hypothesis: p<= 62.3% (the best arm of RTOG 94-10); alternative hypothesis:  p>= 77.9%. Where p is the percentage of patients alive at at 12 months.  Using a one-group chi-square test with alpha = 0.10, a sample size of 50 patients provides at least 87% power to detect a 25% or greater relative increase in the 12-month survival rate, or equivalently, an absolute increase of at least 15.6 percentage points (62.3 versus 77.9).  If the point estimate is greater than 71.1% (upper bound), then the conclusion is that the 12-month survival rate from the new treatment significantly improved from 62.3%.", 
                "measure": "Percentage of Patients Who Survive at Least 12 Months", 
                "safety_issue": "No", 
                "time_frame": "From registration to 1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00023673"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "20368547", 
                "citation": "Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol. 2010 May 10;28(14):2475-80. doi: 10.1200/JCO.2009.27.1205. Epub 2010 Apr 5."
            }, 
            {
                "PMID": "20457350", 
                "citation": "Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):367-72. doi: 10.1016/j.ijrobp.2009.04.029."
            }, 
            {
                "citation": "Bradley JD, Graham M, Suzanne S, et al.: Phase I results of RTOG L-0117: a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. [Abstract] J Clin Oncol 23 (Suppl 16): A-7063, 636s, 2005."
            }
        ], 
        "secondary_outcome": [
            {
                "measure": "Toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "From start of treatment to end of follow-up"
            }, 
            {
                "measure": "Partial Organ Tolerance Doses for Lung and Esophagus", 
                "safety_issue": "Yes", 
                "time_frame": "From start of treatment to end of follow-up"
            }, 
            {
                "measure": "Complete Response Rate at 3 Months After Therapy", 
                "safety_issue": "No", 
                "time_frame": "From start of treatment until 3 months after completion of therapy"
            }
        ], 
        "source": "Radiation Therapy Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Radiation Therapy Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2001", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }, 
    "geocoordinates": {
        "Albert Einstein Cancer Center": "39.952 -75.164", 
        "Alexian Brothers Radiation Oncology": "42.004 -87.97", 
        "Arizona Oncology Services Foundation": "33.448 -112.074", 
        "Bay Medical": "30.159 -85.66", 
        "CCOP - Cancer Research for the Ozarks": "37.209 -93.292", 
        "CCOP - Hematology-Oncology Associates of Central New York": "43.065 -76.079", 
        "CCOP - St. Louis-Cape Girardeau": "38.627 -90.199", 
        "Cancer Center at Ball Memorial Hospital": "40.193 -85.386", 
        "Cancer Institute of Cape Girardeau, LLC": "37.306 -89.518", 
        "Cancer Treatment Center": "40.805 -81.935", 
        "Cleveland Clinic Cancer Center at Fairview Hospital": "41.499 -81.695", 
        "Cleveland Clinic Taussig Cancer Center": "41.499 -81.695", 
        "David C. Pratt Cancer Center at St. John's Mercy": "38.627 -90.199", 
        "Dubs Cancer Center at Rogue Valley Medical Center": "42.327 -122.876", 
        "Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare": "39.486 -75.026", 
        "Good Samaritan Regional Health Center": "38.317 -88.903", 
        "Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center": "43.801 -91.24", 
        "High Point Regional Hospital": "35.956 -80.005", 
        "Hulston Cancer Center at Cox Medical Center South": "37.209 -93.292", 
        "J. Phillip Citta Regional Cancer Center at Community Medical Center": "39.954 -74.198", 
        "Joe Arrington Cancer Research and Treatment Center": "33.578 -101.855", 
        "Medical College of Wisconsin Cancer Center": "43.039 -87.906", 
        "Mobile Infirmary Medical Center": "30.694 -88.043", 
        "Northeast Georgia Medical Center": "34.298 -83.824", 
        "Ocean Medical Center at Meridian Health": "40.058 -74.11", 
        "Oncology Center at Saint Margaret Mercy Healthcare Center": "41.583 -87.5", 
        "Providence Cancer Center at PMCC": "42.327 -122.876", 
        "Providence Holy Cross Cancer Center": "34.688 -120.436", 
        "Providence Saint Joseph Medical Center - Burbank": "34.181 -118.309", 
        "Rapid City Regional Hospital": "44.081 -103.231", 
        "Regional Cancer Center at Singing River Hospital": "30.366 -88.556", 
        "Saint Anthony's Hospital at Saint Anthony's Health Center": "38.891 -90.184", 
        "Saint Francis Medical Center": "37.306 -89.518", 
        "Schiffler Cancer Center at Wheeling Hospital": "40.064 -80.721", 
        "Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital": "37.329 -89.512", 
        "Summa Center for Cancer Care at Akron City Hospital": "41.081 -81.519", 
        "Three Rivers Community Hospital": "42.439 -123.328", 
        "Tom Baker Cancer Centre - Calgary": "51.045 -114.057", 
        "University of California Davis Cancer Center": "38.582 -121.494", 
        "University of Texas Medical Branch": "29.301 -94.798", 
        "Veterans Affairs Medical Center - Milwaukee": "43.039 -87.906"
    }
}